Uncategorized
Featured Stories
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
DaVita Inc. to Participate in TD Cowen’s 46th Annual Health Care Conference
Forging the Future of Chronic Care: 3 Ways Tech is Helping Transform the Patient Experience
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
DaVita Sets Purchase Price in Tender Offer and Consent Solicitation For Its 9.25% Senior Subordinated Notes Due 2011
DaVita Inc. today announced the consideration to be paid in its cash tender offer for all of its outstanding 9.25% Senior Subordinated Notes due 2011. The tender offer is subject to the terms and…
-
DaVita Announces Receipt of Requisite Consents for its 9.25% Senior Subordinated Notes Due 2011
DaVita Inc. today announced that, as of 5:00 PM, Eastern Standard Time, April 4, 2002 (the expiration date of the consent solicitation period), it had received the requisite consents from the…
-
Frequently Asked Questions Regarding DaVita Inc.’s Tender Offer to Buy Up to 24 Million Shares of Its Common Stock
DaVita Inc. is providing the following additional information, in the form of questions and answers, regarding its Tender Offer to purchase up to 24 million shares of its common stock. These…
-
DaVita Inc. Commences Tender Offers to Buy up to 24,000,000 Shares of Its Common Stock and Its 9.25% Senior Subordinated Notes due 2011
DaVita Inc. today commenced its previously announced tender offers for up to 24,000,000 shares of its common stock and any or all of its outstanding 91/4% Senior Subordinated Notes due 2011….
-
DaVita Inc. Plans to Buy up to 25,000,000 Shares of Its Common Stock And Its 91/4% Senior Subordinated Notes Due 2011
DaVita Inc. announced today its plans to repurchase up to 25,000,000 shares of its common stock and any or all of its outstanding 91/4% Senior Subordinated Notes due 2011. DaVita expects to enter…